% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/Design-methods.R
\name{simulate,DualDesign-method}
\alias{simulate,DualDesign-method}
\title{Simulate outcomes from a dual-endpoint design}
\usage{
\S4method{simulate}{DualDesign}(
  object,
  nsim = 1L,
  seed = NULL,
  trueTox,
  trueBiomarker,
  args = NULL,
  sigma2W,
  rho = 0,
  firstSeparate = FALSE,
  mcmcOptions = McmcOptions(),
  parallel = FALSE,
  nCores = min(parallel::detectCores(), 5),
  derive = list(),
  ...
)
}
\arguments{
\item{object}{the \code{\linkS4class{DualDesign}} object we want to simulate
data from}

\item{nsim}{the number of simulations (default: 1)}

\item{seed}{see \code{\link{set_seed}}}

\item{trueTox}{a function which takes as input a dose (vector) and returns the
true probability (vector) for toxicity. Additional arguments can be supplied
in \code{args}.}

\item{trueBiomarker}{a function which takes as input a dose (vector) and
returns the true biomarker level (vector). Additional arguments can be
supplied in \code{args}.}

\item{args}{data frame with arguments for the \code{trueTox} and
\code{trueBiomarker} function. The column names correspond to the argument
names, the rows to the values of the arguments. The rows are appropriately
recycled in the \code{nsim} simulations.}

\item{sigma2W}{variance for the biomarker measurements}

\item{rho}{correlation between toxicity and biomarker measurements (default:
0)}

\item{firstSeparate}{enroll the first patient separately from the rest of
the cohort? (not default) If yes, the cohort will be closed if a DLT occurs
in this patient.}

\item{mcmcOptions}{object of class \code{\linkS4class{McmcOptions}},
giving the MCMC options for each evaluation in the trial. By default,
the standard options are used}

\item{parallel}{should the simulation runs be parallelized across the
clusters of the computer? (not default)}

\item{nCores}{how many cores should be used for parallel computing?
Defaults to the number of cores on the machine, maximum 5.}

\item{derive}{a named list of functions which derives statistics, based on the
vector of posterior MTD samples. Each list element must therefore accept
one and only one argument, which is a numeric vector, and return a number.}

\item{\dots}{not used}
}
\value{
an object of class \code{\linkS4class{DualSimulations}}
}
\description{
Simulate outcomes from a dual-endpoint design
}
\examples{
# nolint start

# Define the dose-grid
emptydata <- DataDual(doseGrid = c(1, 3, 5, 10, 15, 20, 25, 40, 50, 80, 100))

# Initialize the CRM model
model <- DualEndpointRW(
  mean = c(0, 1),
  cov = matrix(c(1, 0, 0, 1), nrow = 2),
  sigma2betaW = 0.01,
  sigma2W = c(a = 0.1, b = 0.1),
  use_log_dose = TRUE,
  ref_dose = 2,
  rho = c(a = 1, b = 1),
  rw1 = TRUE
)

# Choose the rule for selecting the next dose
myNextBest <- NextBestDualEndpoint(
  target = c(0.9, 1),
  overdose = c(0.35, 1),
  max_overdose_prob = 0.25
)

# Choose the rule for the cohort-size
mySize1 <- CohortSizeRange(
  intervals = c(0, 30),
  cohort_size = c(1, 3)
)
mySize2 <- CohortSizeDLT(
  intervals = c(0, 1),
  cohort_size = c(1, 3)
)
mySize <- maxSize(mySize1, mySize2)

# Choose the rule for stopping
myStopping4 <- StoppingTargetBiomarker(
  target = c(0.9, 1),
  prob = 0.5
)
myStopping <- myStopping4 | StoppingMinPatients(10)

# Choose the rule for dose increments
myIncrements <- IncrementsRelative(
  intervals = c(0, 20),
  increments = c(1, 0.33)
)

# Initialize the design
design <- DualDesign(
  model = model,
  data = emptydata,
  nextBest = myNextBest,
  stopping = myStopping,
  increments = myIncrements,
  cohort_size = mySize,
  startingDose = 3
)

# define scenarios for the TRUE toxicity and efficacy profiles
betaMod <- function(dose, e0, eMax, delta1, delta2, scal) {
  maxDens <- (delta1^delta1) *
    (delta2^delta2) /
    ((delta1 + delta2)^(delta1 + delta2))
  dose <- dose / scal
  e0 + eMax / maxDens * (dose^delta1) * (1 - dose)^delta2
}

trueBiomarker <- function(dose) {
  betaMod(
    dose,
    e0 = 0.2,
    eMax = 0.6,
    delta1 = 5,
    delta2 = 5 * 0.5 / 0.5,
    scal = 100
  )
}

trueTox <- function(dose) {
  pnorm((dose - 60) / 10)
}

# Draw the TRUE profiles
par(mfrow = c(1, 2))
curve(trueTox(x), from = 0, to = 80)
curve(trueBiomarker(x), from = 0, to = 80)

# Run the simulation on the desired design
# We only generate 1 trial outcome here for illustration, for the actual study
# this should be increased of course, similarly for the McmcOptions -
# they also need to be increased.
mySims <- simulate(
  design,
  trueTox = trueTox,
  trueBiomarker = trueBiomarker,
  sigma2W = 0.01,
  rho = 0,
  nsim = 1,
  parallel = FALSE,
  seed = 3,
  startingDose = 6,
  mcmcOptions = McmcOptions(
    burnin = 100,
    step = 1,
    samples = 300
  )
)

# nolint end
}
\keyword{methods}
